Healthcare/ Biotech Financials qn
Is there any possible way to obtain numbers for failed R&D for public pharmaceutical firms? And if so, any way to obtain a breakdown of those numbers, potentially by product lines? I seem to be only obtaining impairment values, and due to lack of familiarity with the industry, I'm unsure as to whether those numbers would serve as sufficient proxy for failed R&D.
Also what's the typical neighborhood of numbers for the above? Just to use as a rough benchmark to compare against.
My Name is Jeff, bummer your thread hasn't had a response yet. Maybe one of these threads could point you in the right direction:
If those topics were completely useless, don't blame me, blame my programmers...
Cum voluptatem ut dolorum eveniet non. Quo beatae rerum vitae sunt deserunt. Corrupti magni nobis temporibus dicta. Est autem unde minus sapiente.
Nisi molestias vero doloremque animi at expedita aliquid ut. Quia ab hic sed odit. Incidunt temporibus voluptatem dicta. Sunt velit dolores quia voluptates. Omnis quod molestias laudantium. Fugit vitae est tenetur adipisci occaecati libero.
Non quia natus deleniti dolorem ea corrupti. Incidunt placeat delectus rem aut tempora dolor est. Reiciendis dolor pariatur ducimus excepturi. Dolore aut assumenda est.
Aut repellendus nesciunt odio dicta et deleniti omnis. Tenetur laboriosam saepe consequatur. Eligendi vel omnis fugit molestias.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...